News and Updates

The UK has set a minimum age of 11 for puberty blocker trials. Learn about the new safety protocols and evidence-based approach to pediatric gender-affirming care.

The FDA has expanded the approval of Skinvive by Juvéderm to treat neck wrinkles. Learn how this hyaluronic acid injectable improves skin smoothness.

The global stem cell therapy market is set to reach $3.65B. Discover the key innovations and market trends driving this rapid growth in regenerative medicine.

Teva has submitted an NDA for ecopipam, a novel D1 receptor antagonist, to treat pediatric Tourette syndrome. Learn about this potential new therapy.

Experts urge the FDA to create a dedicated regulatory pathway for vaccine-based dementia prevention trials to accelerate breakthroughs in neuro-immunology.

The USFDA has approved CAPVAXIVE for children and teens at high risk of pneumococcal disease. Learn about this new vaccine's role in pediatric prevention.

New research reveals that paid paternity leave significantly lowers depression and stress in new fathers, fostering stronger family health and wellbeing.

New data confirms zero cervical cancer deaths in women vaccinated against HPV in England, highlighting the life-saving impact of immunization programs.

HHS has mandated critical safety label updates for testosterone therapy drugs to improve patient safety, clinical monitoring, and reduce misuse risks.

Discover how new clinical trial standards for HCC are set to improve research design, patient outcomes, and the development of breakthrough liver cancer drugs.